Effect of hemodialysis schedules and membranes on hepatocyte growth factor and hepatitis C virus RNA levels

Journal of Medical Virology

Volumn 82, Issue 5, 2010, Pages 763-767

  Barril, Guillermina ^a   Bartolomé, Javier ^b   Sanz, Paloma ^a   Buoncristiani, Emmanuela ^c   Traver, Juan Antonio ^a   Selgas, Rafael ^a   Buoncristiani, Umberto ^c   Castillo, Inmaculada ^b   Quiroga, Juan Antonio ^b   Carreño, Vicente ^b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Fundacion para el Estudio de Las Hepatitis Virales   (Spain)

^c Ospedale San Silvestrini   (Italy)

Author keywords

HCV RNA; Hemodialysis; HGF

Indexed keywords

SCATTER FACTOR; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; DIALYSIS MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; NONHUMAN; SERUM; TREATMENT OUTCOME; VIREMIA;

AGED; FEMALE; HEPACIVIRUS; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MEMBRANES; MIDDLE AGED; RENAL DIALYSIS; RNA, VIRAL; TIME FACTORS; VIRAL LOAD;

HEPATITIS C VIRUS;

EID: 77951017159     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21469     Document Type: Article

References (28)

1. Akpolat I, Ozylkan E, Karagöz F, Akpolat T, Kandemir B. 1998. Hepatitis C in hemodialysis and non-uremic patients: A histopathological study. Int Urol Nephrol 30:349-355. (Pubitemid 28462229)
2. Badalamenti S, Catania A, Lunghi G, Covini G, Bredi E, Brancaccio D, Salvadori M, Como G, Ponticelli C, Graziani G. 2003. Changes in viremia and circulating interferon-alpha during hemodialysis in hepatitis C virus-positive patients: Only coincidental phenomena? Am J Kidney Dis 42:143-150.
3. Bouchardeau F, Chauveau P, Le Marrec N, Girault A, Zins B, Couroucé AM. 1993. Detection of hepatitis C virus by polymerase chain reaction in hemodialysis patients in relationship to anti-HCV status. Res Virol 144:233-242. (Pubitemid 23198289)
4. Chan TM, Lok AS, Cheng IK, Chan RT. 1993. Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays. Hepatology 17: 5-8.
5. Davis GL. 1994. Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol 21:1-3. (Pubitemid 24236672)
6. Fabrizi F, Bunnapradist S, Lunghi G, Martin P. 2003. Kinetics of hepatitis C virus load during hemodialysis: Novel perspectives. J Nephrol 4:467-475. (Pubitemid 38120456)
7. Herberlin A, Nguyen AT, Zingraff J, Ureña P, Descamps-Latscha B. 1990. Influence of uremia and hemodialysis on circulating interleukin- 1 and tumor necrosis factor. Kidney Int 37:116-125. (Pubitemid 20023775)
8. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. 1992. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16:1227-1235.
9. Khan KN, Masuzaki H, Fujishita A, Kitajima M, Hiraki K, Sekine I, Matsuyama T, Ishimaru T. 2005. Interleukin-6 and tumor necrosis factor a-mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis. Hum Reprod 20:2715-2723.
10. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanovski JA, Veis JH. 1998. Immunologic function and survival in hemodialysis patients. Kidney Int 54:236-244.
11. Liu Y, Lin L, Zarnegar R. 1994. Modulation of hepatocyte growth factor gene expression by estrogen in mouse ovary. Mol Cell Endocrinol 104:173-181. (Pubitemid 24253799)
12. Matsumoto K, Tajima H, Okazaki H, Nakamura T. 1992. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblast and leukemic cells by transforming growth factor β1 and glucocorticoids. J Biol Chem 267:24917-24920.
13. Memoli B, Libetta C, Rampino T, Dal Canton A, Conte G, Scala G, Ruocco MR, Andreucci VE. 1992. Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int 42:320-326.
14. Mizuno M, Higuchi T, Yanai M, Kanmatsuse K, Esumi M. 2002. Dialysis-membrane-dependent reduction and adsorption of circulating hepatitis C virus during hemodialysis. Nephron 2:235-242. (Pubitemid 34621689)
15. Nelson DR. 2001. The immunopathogenesis of hepatitis C virus infection. Clin Liver Dis 5:931-953.
16. Okuda K, Hayashi H, Yokozeki K. 1996. Destruction of hepatitis C virus particles by hemodialysis. Lancet 347:909-910. (Pubitemid 26099570)
17. Petrosillo N, Puro V, Ippolito G. 1993. Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among dialysis patients. Nephron 64:636-639. (Pubitemid 23225340)
18. Rampino T, Libetta C, De Simone W, Ranghino A, Soccio G, Gregorini M, Guallini P, Tamagnone L, Dal Canton A. 1998. Hemodialysis stimulates hepatocyte growth factor release. Kidney Int 53:1382-1388. (Pubitemid 28316902)
19. Rampino T, Arbustini E, Gregorini M, Guallini P, Libetta C, Maggio M, Ranghino A, Silini E, Soccio G, Dal Canton A. 1999. Hemodialysis prevents liver disease caused by hepatitis C virus: Role of hepatocyte growth factor. Kidney Int 56:2286-2291.
20. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. 1995. Serum hepatocyte growth factor levels in liver diseases: Clinical implications. Hepatology 21:106-112.
21. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C. 1993. Scatter factor/hepatocyte growth factor and its receptor the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelial during mouse development. J Cell Biol 123:223-235. (Pubitemid 23284877)
22. Tamura M, Arakaki N, Tsubouchi H, Takada H, Daikuhara Y. 1993. Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and 1-beta and tumor necrosis factor-alpha by fibroblast in culture. J Biol Chem 68:8140-8145. (Pubitemid 23120397)
23. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S, Setouguchi M, Tachikawa T, Shin S, Arima T, Daikuhara Y. 1991. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 13:1-5.
24. Umlanft F, Gruenewald K, Weiss G, Kessler H, Urbanek M, Haun M, Santner B, Koenig P, Keeffe EB. 1997. Patterns of hepatitis C viremia in patients receiving hemodialysis. Am J Gastroenterol 92:73-78. (Pubitemid 27027032)
25. Van Riemsdijk-van Overbeeke IC, Baan CC, Knoop CJ, Loonen EH, Zietse R, Weimar W. 2001. Quantitative flow cytometry shows activation of TNF-α but not of the IL-2 system at the single cell level in renal replacement therapy. Nephrol Dial Transplant 16:1430-1435. (Pubitemid 32640599)
26. Wolf H, Zarnegar R, Oliver L, Michalopoulos G. 1991. Hepatocyte growth factor in human placenta and trophoblastic disease. Am J Pathol 138:1035-1043.
27. Zarnegar R, Michaloupolos GK. 1989. Purification and biological characterization of human hepatopoietin A: A polypeptide growth factor for hepatocytes. Cancer Res 49:3314-3320. (Pubitemid 19162144)
28. Zarnegar R, Muga S, Rahija R, Michalopoulos G. 1990. Tissue distribution of hepatopoietin A: A heparin binding polypeptide growth factor for hepatocytes. Proc Natl Acad Sci USA 87:1252-1256. (Pubitemid 20057204)